Skip to main content
. 2019 Feb 22;11(1):e011127. doi: 10.1136/heartasia-2018-011127

Figure 2.

Figure 2

Relationship between the reduction in blood pressure (BP) and the risk of composite cardiovascular endpoints (triple: myocardial infarction, stroke and cardiovascular death; quadruple: myocardial infarction, stroke, cardiovascular death and congestive heart failure). Thirty trials are included for a total of 221 024 patients. For each trial, the difference in BP between randomised groups is depicted. Data from Verdecchia et al 21 (with permission). BP, blood pressure.